Wendy Bruening

Title: Innovations of Wendy Bruening

Introduction

Wendy Bruening is a notable inventor based in Lower Gwynedd, PA (US). She has made significant contributions to the field of genetics, particularly in the study of the Wilms' tumor gene. With a total of 2 patents, her work has implications for understanding kidney and gonadal tissue development.

Latest Patents

Wendy's latest patents focus on the localization and characterization of the Wilms' tumor gene associated with the 11p3 locus on the human chromosome. This gene encodes a transcription unit approximately 50 kb in size and an mRNA of approximately 3 kb, predominantly expressed in kidney and gonadal tissue. The gene undergoes alternative splicing, producing four very similar mRNA transcripts. The polypeptides encoded by the Wilms' tumor DNA include four 'zinc fingers' and a region rich in proline and glutamine, suggesting a role in transcription regulation.

Career Highlights

Wendy Bruening is affiliated with the Massachusetts Institute of Technology, where she continues her research and innovation in genetics. Her work has garnered attention for its potential impact on cancer research and treatment.

Collaborations

Wendy has collaborated with notable colleagues, including Katherine M Call and Jerry M Pelletier, enhancing the depth and breadth of her research.

Conclusion

Wendy Bruening's contributions to the field of genetics, particularly through her patents on the Wilms' tumor gene, highlight her role as an influential inventor. Her work continues to pave the way for advancements in understanding genetic disorders.